JLE

Médecine et Santé Tropicales

MENU

New technologies for controlling emerging infectious diseases in Guinea and the Democratic Republic of the Congo: their role in response to the Ebola epidemic Volume 29, issue 4, Octobre-Novembre-Décembre 2019

Figures


  • Figure 1

  • Figure 2

  • Figure 3
Authors
1 Recherches translationnelles sur VIH et maladies infectieuses/Institut national de la santé et de la recherche médicale 1175, Institut de recherche pour le développement et Université de Montpellier, France
2 Institut national de recherche biomédicale, Kinshasa, République démocratique du Congo (RDC)
3 Centre de recherche et de formation en infectiologie de Guinée (Cerfig), Université Gamal Abdel Nasser de Conakry, Guinée
4 Institut national de santé publique (INSP), Conakry, Guinée
5 Chaire de Sante Publique, Université Gamal Abdel Nasser de Conakry, Guinée
* Correspondance

Emerging infectious diseases appear recurrently and represent a threat to global health security. Africa is particularly exposed to the risks of infectious epidemics, due to both the number of circulating infectious agents, especially in wildlife, and the social and environmental factors that promote their epidemic spread. Ebola outbreaks in West Africa in 2014 and those in the DRC that began in 2018 were an opportunity to develop and deploy new diagnostic techniques in laboratories in Guinea and the Democratic Republic of the Congo (DRC). These tools made it possible to identify the infectious agent rapidly, to trace contamination chains in real time to enable effective interventions, and to develop a reliable serological tool for differential diagnoses. Today, equipped and functional facilities exist in both countries, led by Guinean and Congolese researchers trained to high levels of competence and benefiting from unique experience and field knowledge.